|
1
|
Global Burden of Disease Cancer
Collaboration, ; Fitzmaurice C, Dicker D, Pain A, Hamavid H,
Moradi-Lakeh M, Maclntyre MF, Allen C, Hansen G, Woodbrook R, et
al: The global burden of cancer 2013. JAMA Oncol. 1:505–527. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Pennathur A, Gibson MK, Jobe BA and
Luketich JD: Oesophageal carcinoma. Lancet. 381:400–412. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Siegel RL, Miller KD and Jemal A: Cancer
Statistics. 2017. CA Cancer J Clin. 67:7–30. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Otte AP and Kwaks TH: Gene repression by
Polycomb group protein complexes: A distinct complex for every
occasion? Curr Opin Genet Dev. 13:448–454. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Levine SS, Weiss A, Erdjument-Bromage H,
Shao Z, Tempst P and Kingston RE: The core of the polycomb
repressive complex is compositionally and functionally conserved in
flies and humans. Mol Cell Biol. 22:6070–6078. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Kuzmichev A, Nishioka K, Erdjument-Bromage
H, Tempst P and Reinberg D: Histone methyltransferase activity
associated with a human multiprotein complex containing the
Enhancer of Zeste protein. Genes Dev. 16:2893–2905. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Bentley ML, Corn JE, Dong KC, Phung Q,
Cheung TK and Cochran AG: Recognition of UbcH5c and the nucleosome
by the Bmi1/Ring1b ubiquitin ligase complex. EMBO J. 30:3285–3297.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Buchwald G, van der Stoop P, Weichenrieder
O, Perrakis A, van Lohuizen M and Sixma TK: Structure and E3-ligase
activity of the Ring-Ring complex of polycomb proteins Bmi1 and
Ring1b. EMBO J. 25:2465–2474. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Li Z, Cao R, Wang M, Myers MP, Zhang Y and
Xu RM: Structure of a Bmi-1-Ring1B polycomb group ubiquitin ligase
complex. J Biol Chem. 281:20643–20649. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ruan ZP, Xu R, Lv Y, Tian T, Wang WJ, Guo
H and Nan KJ: Bmi1 knockdown inhibits hepatocarcinogenesis. Int J
Oncol. 42:261–268. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Song W, Tao K, Li H, Jin C, Song Z, Li J,
Shi H, Li X, Dang Z and Dou K: Bmi-1 is related to proliferation,
survival and poor prognosis in pancreatic cancer. Cancer Sci.
101:1754–1760. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Sánchez-Beato M, Sánchez E,
González-Carreró J, Morente M, Díez A, Sánchez-Verde L, Martín MC,
Cigudosa JC, Vidal M and Piris MA: Variability in the expression of
polycomb proteins in different normal and tumoral tissues. A pilot
study using tissue microarrays. Mod Pathol. 19:684–694. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Bosch A, Panoutsopoulou K, Corominas JM,
Gimeno R, Moreno-Bueno G, Martín-Caballero J, Morales S, Lobato T,
Martínez-Romero C, Farias EF, et al: The Polycomb group protein
RING1B is overexpressed in ductal breast carcinoma and is required
to sustain FAK steady state levels in breast cancer epithelial
cells. Oncotarget. 5:2065–2076. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Su WJ, Fang JS, Cheng F, Liu C, Zhou F and
Zhang J: RNF2/Ring1b negatively regulates p53 expression in
selective cancer cell types to promote tumor development. Proc Natl
Acad Sci USA. 110:1720–1725. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Yang XX, Ma M, Sang MX, Wang XX, Song H,
Liu ZK and Zhu SC: Radiosensitization of esophageal carcinoma cells
by knockdown of RNF2 expression. Int J Oncol. 48:1985–1996. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Yang XX, Ma M, Sang MX, Zhang XY, Liu ZK,
Song H and Zhu SC: BMI-1 suppression increases the radiosensitivity
of oesophageal carcinoma via the PI3K/Akt signaling pathway. Oncol
Rep. 39:667–678. 2018.PubMed/NCBI
|
|
17
|
Edge SB, Byrd DR, Compton CC, Fritz AG,
Greene FL and Trotti A: AJCC Cancer Staging Mamal. 7th.
Springer-Verlag; New York, NY: pp. 103–15. 2009
|
|
18
|
Masunaga R, Kohno H, Dhar DK, Ohno S,
Shibakita M, Kinugasa S, Yoshimura H, Tachibana M, Kubota H and
Nagasue N: Cyclooxygenase-2 expression correlates with tumor
neovascularization and prognosis in human colorectal carcinoma
patients. Clin Cancer Res. 6:4064–4068. 2000.PubMed/NCBI
|
|
19
|
Wu D, Ding Y, Wang S, Zhang Q and Liu L:
Increased expression of high mobility group box 1 (HMGB1) is
associated with progression and poor prognosis in human
nasopharyngeal carcinoma. J Pathol. 216:167–175. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Chen J, Xu H, Zou X, Wang J, Zhu Y, Chen
H, Shen B, Deng X, Zhou A, Chin YE, et al: Snail recruits Ring1B to
mediate transcriptional repression and cell migration in pancreatic
cancer cells. Cancer Res. 74:4353–4363. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Chen S, Chen J, Zhan Q, Zhu Y, Chen H,
Deng X, Hou Z, Shen B, Chen Y and Peng C: H2AK119Ub1 and H3K27Me3
in molecular staging for survival prediction of patients with
pancreatic ductal adenocarcinoma. Oncotarget. 5:10421–10433.
2014.PubMed/NCBI
|
|
22
|
Rai K, Akdemir KC, Kwong LN, Fiziev P, Wu
CJ, Keung EZ, Sharma S, Samant NS, Williams M, Axelrad JB, et al:
Dual Roles of RNF2 in melanoma progression. Cancer Discov.
5:1314–1327. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
van der Stoop P, Boutsma EA, Hulsman D,
Noback S, Heimerikx M, Kerkhoven RM, Voncken JW, Wessels LF and van
Lohuizen M: Ubiquitin E3 ligase Ring1b/Rnf2 of polycomb repressive
complex 1 contributes to stable maintenance of mouse embryonic stem
cells. PLoS One. 3:e22352008. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
van der Velden YU, Wang L, Querol Cano L
and Haramis AP: The polycomb group protein ring1b/rnf2 is
specifically required for craniofacial development. PLoS One.
8:e739972013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zhang XJ, Yu HY, Cai YJ and Ke M: Lycium
barbarum polysaccharides inhibit proliferation and migration of
bladder cancer cell lines BIU87 by suppressing Pi3K/AKT pathway.
Oncotarget. 8:5936–5942. 2017.PubMed/NCBI
|
|
26
|
Bussink J, van der Kogel AJ and Kaanders
JH: Activation of the PI3-K/AKT pathway and implications for
radioresistance mechanisms in head and neck cancer. Lancet Oncol.
9:288–296. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Deng R, Tang J, Ma JG, Chen SP, Xia LP,
Zhou WJ, Li DD, Feng GK, Zeng YX and Zhu XF: PKB/Akt promotes DSB
repair in cancer cells through upregulating Mre11 expression
following ionizing radiation. Oncogene. 30:944–955. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zhang Y, Zheng L, Ding Y, Li Q, Wang R,
Liu T, Sun Q, Yang H, Peng S, Wang W and Chen L: MiR-20a induces
cell radioresistance by activating the PTEN/PI3K/Akt signaling
pathway in hepatocellular carcinoma. Int J Radiat Oncol Biol Phys.
92:1132–1140. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Yoshioka A, Miyata H, Doki Y, Yasuda T,
Yamasaki M, Motoori M, Okada K, Matsuyama J, Makari Y, Sohma I, et
al: The activation of Akt during preoperative chemotherapy for
esophageal cancer correlates with poor prognosis. Oncol Rep.
19:1099–1107. 2008.PubMed/NCBI
|
|
30
|
Schmitz KJ, Otterbach F, Callies R, Levkau
B, Hölscher M, Hoffmann O, Grabellus F, Kimmig R, Schmid KW and
Baba HA: Prognostic relevance of activated Akt kinase in
node-negative breast cancer: A clinicopathological study of 99
cases. Mod Pathol. 17:15–21. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Wang L, Liu JL, Yu L, Liu XX, Wu HM, Lei
FY, Wu S and Wang X: Downregulated miR-495 [Corrected] inhibits the
G1-S Phase transition by targeting Bmi-1 in breast cancer. Medicine
(Baltimore). 94:e7182015. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Jin M, Zhang T, Liu C, Badeaux MA, Liu B,
Liu R, Jeter C, Chen X, Vlassov AV and Tang DG: miRNA-128
suppresses prostate cancer by inhibiting BMI-1 to inhibit
tumor-initiating cells. Cancer Res. 74:4183–4195. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Yang F, Lv LZ, Cai QC and Jiang Y:
Potential roles of EZH2, Bmi-1 and miR-203 in cell proliferation
and invasion in hepatocellular carcinoma cell line Hep3B. World J
Gastroenterol. 21:13268–13276. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Richly H, Aloia L and Di Croce L: Roles of
the Polycomb group proteins in stem cells and cancer. Cell Death
Dis. 2:e2042011. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Wang H, Wang L, Erdjument-Bromage H, Vidal
M, Tempst P, Jones RS and Zhang Y: Role of histone H2A
ubiquitination in Polycomb silencing. Nature. 431:873–878. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Rao PS, Satelli A, Zhang S, Srivastava SK,
Srivenugopal KS and Rao US: RNF2 is the target for phosphorylation
by the p38 MAPK and ERK signaling pathways. Proteomics.
9:2776–2787. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Shi HY and Zhu SC: Radiosensitization of
esophageal cancer cells ECA109 by knockdown of H2AX. Thorac Cancer.
4:254–263. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Ohtsubo M, Yasunaga S, Ohno Y, Tsumura M,
Okada S, Ishikawa N, Shirao K, Kikuchi A, Nishitani H, Kobayashi M
and Takihara Y: Polycomb-group complex 1 acts as an E3 ubiquitin
ligase for Geminin to sustain hematopoietic stem cell activity.
Proc Natl Acad Sci USA. 105:10396–10401. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Sen N, Satija YK and Das S: PGC-1α, a key
modulator of p53, promotes cell survival upon metabolic stress. Mol
Cell. 44:621–634. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Ben-Saadon R, Zaaroor D, Ziv T and
Ciechanover A: The polycomb protein Ring1B generates self atypical
mixed ubiquitin chains required for its in vitro histone H2A ligase
activity. Mol Cell. 24:701–711. 2006. View Article : Google Scholar : PubMed/NCBI
|
